v3.26.1
EQUITY COMPENSATION PLANS (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of RSAs transaction activity
          
   Restricted
Common Stock
Award Shares
  Weighted Average
Grant Date Fair
Value ($)
Unvested balance at December 31, 2025   17,617    3.10 
Granted        
Vested   (5,049)   2.11 
Forfeited        
Unvested balance at June 30, 2026   12,568    3.50 
Schedule of RSUs transaction activity
          
   Restricted
Common Stock
Unit Shares
  Weighted Average
Grant Date Fair
Value ($)
Outstanding at December 31, 2025   617,236    9.13 
Granted        
Vested and settled   (342,055)   9.14 
Forfeited        
Outstanding at June 30, 2026   275,181    9.13 
Unvested at June 30, 2026   275,181    9.13 
Schedule of stock option transaction activity
          
   Number of
Stock Options
  Grant Date
Weighted
Average
Exercise Price
($)
Outstanding at December 31, 2025   1,841,977    6.51 
Options granted   950,000    2.48 
Options exercised        
Options canceled and forfeited   (36,141)   4.85 
Outstanding at June 30, 2026   2,755,836    5.14 
Schedule of assumptions
     
Expected volatility   99.95% 
Risk-free interest rate   4.03% 
Expected dividend yield   0.00% 
Expected term (in years)   6.01 
Schedule of stock-based compensation expense
                    
   Three Months Ended June 30,  Six Months Ended June 30,
   2026  2025  2026  2025
Research and development  $195,048   $88,363   $351,718   $217,289 
General and administrative   1,145,721    1,490,908    2,345,440    2,487,083 
Total  $1,340,769   $1,579,271   $2,697,158   $2,704,372